Connor Iapoce

Adults with obstructive sleep apnea who receivied tirzepatide achieved an average of up to 20% weight loss and experienced at least 25 fewer breathing interruptions for each hour slept.

The collaborative newly published statement stressed the need to address gaps in care that may lead to high risk of stroke recurrence.